News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB transmission and prevention news

Show

From To
TB transmission and prevention
Community-level preventive TB therapy in South African gold miners fails to bring down overall incidence

Individuals still saw TB incidence reduction of two-thirds, but effect was not durable Preliminary results from the Thibela Project – which looked at whether community-wide provision of isoniazid preventive therapy (IPT) in South African gold mines would improve TB control in these high-incidence sites.

Published
12 March 2012
From
Science Speaks
TB transmission and prevention
SOUTH AFRICA: Preventative TB trial disappoints

After seven years of research, the world's largest study of preventative tuberculosis (TB) therapy has found that untargeted, community-wide distribution of TB prevention drugs did not improve TB control on South African gold mines.

Published
09 March 2012
From
IRIN Plus News
TB diagnosis
Strengthening labs and introducing new tools for increased case detection and earlier diagnosis of TB

This edition looks at the relationship between strengthening of laboratory diagnostic capacity and intensified case finding for TB in people living with HIV

Published
20 January 2012
From
HIV & AIDS treatment in practice
TB transmission and prevention
Short-Term TB Combination as Successful as Isoniazid Therapy

Weekly rifapentine plus isoniazid given under direct supervision for 3 months was as effective in preventing tuberculosis (TB) as 9 months of daily self-administered isoniazid, according to a report published in the December 8 issue of the New England Journal of Medicine.

Published
09 December 2011
From
Medscape (requires free registration)
TB transmission and prevention
CDC releases new 12-dose treatment guidelines for latent TB infection

The Centers for Disease Control and Prevention (CDC) unveiled new guidelines Thursday for the treatment of latent tuberculosis infection (LTBI) in the U.S. with a 12-dose regimen, administered once-weekly under directly observed therapy (DOT). The current regimen requires daily drug administration over nine months, making the new treatment simpler and easier for patients.

Published
08 December 2011
From
Science Speaks
HIV and TB in Practice: Going beyond the clinic to eliminate TB and TB/HIV

Thanks to the following for their advice: Dr Liz Corbett,  Professor Helen Ayles and Professor Peter Godfrey-Faussett of the London School of Hygiene and Tropical

Published
06 December 2011
From
HIV & AIDS treatment in practice
TB transmission and prevention
ART and TB prevention

This edition explores what is known about the potential benefits and limits of antiretroviral therapy (ART) for TB prevention and control.

Published
25 November 2011
From
HIV & AIDS treatment in practice
TB transmission and prevention
New TB roadmap emphasizes critical role of research

“Elimination of tuberculosis (TB) is more than an aspiration. We know it could become a reality, but this will happen only if we achieve radical transformation in the way TB is diagnosed, treated and prevented. This goal can be realized only if TB research is intensified and envisioned in an entirely new way.”

Published
02 November 2011
From
Tuberculosis Vaccine Initiative (TBVI)
TB transmission and prevention
SOUTHERN AFRICA: Door-to-door outreach cuts TB prevalence

Home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent, according to findings of a large, two-country study released at the International Lung Health Conference in Lille, France.

Published
01 November 2011
From
IRIN Plus News
TB transmission and prevention
Potential vaccine readies immune system to kill tuberculosis in mice

Researchers have developed a potential vaccine against tuberculosis that completely eliminates tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response.

Published
31 October 2011
From
Science Daily
← Prev1...1112131415...17Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.